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Unusual clusters of YY1 binding sites are located
within several differentially methylated regions
(DMRs), including Xist, Nespas and Peg3, which
all become methylated during oogenesis. In this
study, we performed conditional YY1 knockdown
(KD) to investigate YY1’s roles in DNA methylation
of these DMRs. Reduced levels of YY1 during spermatogenesis did not cause any major change in
these DMRs although the same YY1 KD caused
hypermethylation in these DMRs among a subset
of aged mice. However, YY1 KD during oogenesis
resulted in the loss of DNA methylation on Peg3
and Xist, but there were no changes on Nespas
and H19. Continued YY1 KD from oogenesis to
the blastocyst stage caused further loss in DNA
methylation on Peg3. Consequently, high incidents
of lethality were observed among embryos that
had experienced the reduced levels of YY1
protein. Overall, the current study suggests that
YY1 likely plays a role in the de novo DNA
methylation of the DMRs of Peg3 and Xist during
oogenesis and also in the maintenance of
unmethylation status of these DMRs during
spermatogenesis.
INTRODUCTION
Genomic imprinting is an unusual mechanism in which
one allele is repressed based on its parental origin.
Imprinted genes are usually associated with CpG islands
at their 50 -ends, and some of these CpG islands show
diﬀerential DNA methylation patterns between the two
alleles (diﬀerentially methylated regions, DMR).
Imprinted genes tend to be clustered within chromosomal
regions, and some of these DMRs are known to control
the imprinting of a given domain as imprinting control
regions (ICRs) (1,2). As compared to other DMRs,
ICRs obtain parental imprinting marks during gametogenesis in the form of DNA methylation (or histone modiﬁcations). However, this DNA methylation on ICRs in

the germline is regarded as a very unusual event since the
promoters of most autosomal genes are protected from
DNA methylation during gametogenesis. ICRs also maintain their allele-speciﬁc DNA methylation patterns in
somatic cells throughout the lifetime of an organism, particularly during early embryogenesis when mammalian
genomes go through the global resetting process of
DNA methylation. This suggests that ICRs may be subject
to special mechanisms for de novo DNA methylation
during gametogenesis and for protection from DNA
demethylation during early embryogenesis (3,4). These
unique aspects of ICRs have been further highlighted by
several recent observations. The testis-speciﬁc factor
CTCFL may interact with PRMT7, a histone-modifying
enzyme, to derive de novo DNA methylation on the
H19-ICR in the germline (5). In addition, mutant mice
lacking Pgc7/Stella and Zfp57 showed target-speciﬁc
loss of DNA methylation on several ICRs during early
embryogenesis, conﬁrming the presence of ICR-speciﬁc
protection mechanisms against genome-wide DNA
demethylation (6–8).
So far, two transcription factors are known to bind
to DMRs: CTCF binds to the DMRs of H19, Kcnq1,
Rasgrf1, Grb10, Dlk1/Gtl2, Tsix and Xist, and YY1
binds to the DMRs of Nespas, Xist, Tsix and Peg3
(9–19). According to a series of studies, CTCF is required
for maintaining the allele-speciﬁc methylation pattern
on the H19-ICR/DMR during early embryogenesis.
However, CTCF is not required to establish DNA methylation during spermatogenesis (20–23). On the other
hand, recent siRNA-based YY1 knockdown (KD) experiments derived a somewhat similar conclusion: YY1 has
roles in the DNA methylation of Xist, Nespas and Peg3.
Both in vitro and in vivo experiments have shown that
reducing the cellular levels of YY1 protein caused
target-speciﬁc changes in the methylation levels of Xist,
Nespas and Peg3 (24,25). Another study using one
mouse knockout line of YY1 also conﬁrmed a signiﬁcant
role for YY1 in the X chromosomal inactivation process
(26). However, these earlier studies did not clarify when
and where the in vivo levels of YY1 protein are critical for
DNA methylation on these DMRs. In the current study,
therefore, we performed a series of YY1 KD experiments
focusing on potential roles for YY1 during gametogenesis
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and early embryogenesis. Our results demonstrate that the
proper level of YY1 protein is required for de novo DNA
methylation of these DMRs during oogenesis.
MATERIALS AND METHODS
Transgenic mice

Isolation of sperm, egg and blastocyst-stage embryos
Sperm was isolated from the epididymis of male mice
according to a previously established protocol (28).
In brief, the retrieved epididymis was incubated at room
temperature for 1 h with gentle rocking in the buﬀer containing 130 mM NaCl, 20 mM Tris, 2 mM EDTA pH 7.4.
After 4 min spin at 2000 r.p.m. on a tabletop centrifuge
(Cat. Centrifuge 5415D, Eppendorf), the precipitated
sperm was washed two more rounds with the same
buﬀer. The isolated sperm was examined under a microscope to measure the total number and purity of each
sperm pool (Supplementary Data 2). The sperm was subsequently used for isolating DNA.
Mature eggs in MII phase were isolated through a
widely used superovulation protocol (28,29). In brief,
female mice were ﬁrst injected subcutaneously with 5 IU
of Pregnant Mare’s Serum (PMS) (Cat. G4877, Sigma),
and the same mice were injected with 5 IU of the human
Chorionic Gonadotropin (hCG) hormone (Cat. C1063,
Sigma) 48 h after the initial injection. These mice were
sacriﬁced 12 h after the second injection, and mature
eggs were isolated from the swollen ampullae of the oviducts. The isolated eggs were incubated in hyaluronidase
solution (Cat. H3506, Sigma) for several minutes to separate them from the cumulus cells, and subsequently
washed three additional times to remove potential somatic
tissue contamination. Finally, the eggs were used to isolate
DNA.
For the isolation of blastocyst-stage embryos, we followed the same ovulation protocol as the above. After
the second injection, however, we put these female mice

Bisulfite conversion and combined bisulfite restriction
analysis (COBRA)
The DNAs isolated from sperm and egg were individually
treated with the bisulﬁte conversion reaction according
to the manufacturer’s protocol (EZ DNA methylation
kit, Zymo Research). The converted DNAs were used as
templates for the PCR reaction using speciﬁc primers
designed to amplify each ICR. The oligonucleotide
sequences for this study are provided as Supplementary
Data 1. PCR was performed with the Maxime PCR
premix kit (Intron Biotech). To determine the DNA
methylation levels of target regions, we used the following
two approaches: (i) the restriction enzyme digestion-based
COBRA (31) and (ii) subcloning and sequencing of each
PCR product. For the COBRA analysis, each PCR product was digested with the two diﬀerent types of restriction
enzymes. The ﬁrst type of enzymes (HpaI, TaqI and HhaI)
recognizes and digests CpGs and thus the digestion by
these enzymes indicates the methylated status of CpGs
in the original DNA. In contrast, the second type of
enzymes (HphI) recognizes and digests TpGs and thus
the digestion in this case indicates the unmethylated
status of CpGs. The methylation levels of a given genomic
DNA can be inferred from the relative ratios of the undigested and digested DNA amounts. Some of the PCR
products were also individually subcloned into the
pGEM T-Easy vector (Promega), and the puriﬁed
DNAs from 10 to 20 clones were sequenced to survey
DNA methylation levels of a given PCR product.
RESULTS
Overall conditional YY1 KD strategy
We have previously established one transgenic mouse line
containing the pSico-YY1 construct, the expression of
which can be activated on by the Cre recombinase
(25; Figure 1A). This previous study has also demonstrated the feasibility of this YY1 KD scheme using the
EIIa-Cre allele. In the current study, we used the same
transgenic line for conditional KD of YY1 during gametogenesis. We crossed heterozygous pSico-YY1 mice with
two germ cell-speciﬁc, homozygous Cre mice: either
Protamine-Cre to target spermatogenesis or Zp3-Cre to
target oogenesis (Figure 1B). The subsequent F1 mice
that were double positive for pSico-YY1 and Pro-Cre
(or Zp3-Cre) were used for the following two experiments.
First, we isolated germ cells from these F1 mice to survey potential changes in the DNA methylation levels
of DMRs. Second, we bred these F1 mice to isolate
blastocyst-stage embryos and also to test the developmental potential of germ cells with the YY1 KD.
The proper YY1 KD by this scheme was also conﬁrmed through independent western blot experiments
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To generate conditional YY1 KD transgenic mice,
SpeI-linearized DNA of the pSico-YY1 shRNA vector
was microinjected into the pronucleus of fertilized eggs
of FVB/NJ backgrounds by The Darwin Transgenic
Mouse Core Facility (Baylor College of Medicine,
Houston, TX, USA) (27). Eight pSico-YY1 (two males
and six females) founder transgenic lines were initially
generated, and conﬁrmed by the expression of EGFP
under a halogen lamp, PCR-based genotyping with tail
DNA, and Southern blot using the DNA fragment containing the U6 promoter as a probe. One F0 transgenic
mouse successfully passed the transgene through its germ
line, and also displayed consistent expression of EGFP.
Thus, this line was used for the current study. Conditional
YY1 KD was performed by crossing this pSico-YY1 line
with two germ cell-speciﬁc Cre mice: the Protamine-Cre
mice [129-Tg(Pro-cre)58Og/J, The Jackson Lab] and
the Zp3-Cre mice [C57BL/6-Tg(Zp3-cre)93Knw/J, The
Jackson Lab]. All the experiments involving mice were
performed in accordance with National Institutes of
Health guidelines for care and use of animals.

together with male littermates. We sacriﬁced the female
mice 3 days after the breeding setup, and ﬂushed the
embryos from their uterus (30). The isolated blastocysts
were further examined under the microscope to estimate
of their developmental stages and purity. Each blastocyst
was individually used to isolate DNA for genotyping.

5658 Nucleic Acids Research, 2009, Vol. 37, No. 17

(Supplementary Data 3). Since the two germ cell-speciﬁc
Cre mice have diﬀerent genetic backgrounds than the
pSico-YY1 mice (Pro-Cre is from 129; Zp3-Cre is from
C57BL; pSico-YY1 is from FVB), we also used the F1
littermates lacking the pSico-YY1 allele as negative controls for the above two sets of experiments.
YY1 KD during spermatogenesis

Figure 1. Overall Strategy of conditional YY1 KD. (A) Schematic representation of the pSico-YY1 shRNA vector. The U6 promoter is
separated from the downstream YY1-shRNA sequence by the EGFP
expression cassette. Cre recombinase, available as a transgenic allele,
recognizes the two TATA-loxP sites and joins these two split regions,
resulting in the production of the YY1 shRNA sequence, which leads
to KD. The sequence in blue is the leader sequence of the U6 RNA
gene, which has been added to increase the stability of the YY1
shRNA, and the sequence in red is the sequence of the YY1 shRNA.
(B) Conditional KD scheme for gametogenesis. The pSico-YY1 transgenic line was crossed with one of two germ cell-speciﬁc Cre mice:
Protamine-Cre for spermatogenesis and Zp3-Cre for oogenesis. The
resulting F1 mice were used for testing potential eﬀects of YY1 KD
during either spermatogenesis or oogenesis.
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Figure 2. YY1 KD eﬀects during spermatogenesis. Sperm DNA was isolated individually from the F1 mice (pSico-YY1, Pro-Cre) and the littermate
controls (+, Pro-Cre). The individual F1 mice are indicated by diﬀerent numbers, while the control littermates are indicated by numbers followed by
C (1C, 5C, 8C and 14C). (A) Individual DNA samples from the 3-month-old set were treated with the bisulﬁte conversion method, followed by the
restriction-enzyme-based method—COBRA. Digestion and lack of digestion by TaqI and ClaI indicate the methylated (M) and unmethylated (U)
status, respectively, of a given CpG site in the original DNA as shown in the digestion of Peg3, Xist, Tsix and H19. In contrast, this is opposite for
the HphI digestion, which recognizes TpG as shown in the digestion of Nespas. Digestion by this enzyme indicates the unmethylated status of a CpG
site, whereas lack of digestion indicates methylation. (B) A subset of the 6-month-old mice is also shown in the same manner as the above. The
results for H19 (8#C and 9) are not available due to the unsuccessful PCR ampliﬁcation.
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To study YY1 KD during spermatogenesis, we prepared
20 male F1 mice (pSico-YY1, Pro-Cre). These mice were

sacriﬁced at three diﬀerent ages, 1, 3 and 6 months old, for
the isolation of sperm DNA. Five F1 mice per time point
were used to isolate sperm from their epididymis. The
remaining ﬁve mice were used for breeding experiments,
which will be described later (Figure 5). Genomic DNA
was puriﬁed from the isolated sperm and used to analyze
DNA methylation via bisulﬁte conversion. The bisulﬁteconverted DNAs were subsequently ampliﬁed with PCR
using speciﬁc primer sets designed for each DMR
(Supplementary Data 1). The ampliﬁed PCR product
from each DMR was analyzed with restriction-digestion
based COBRA (31) and/or subcloning and sequencing
(Figure 2).
Sperm from the 3-month-old F1 mice with YY1 KD did
not show any change in the DNA methylation levels of the
YY1-associated DMRs, including Peg3, Xist, and Nespas
(Figure 2A). Five diﬀerent samples of sperm DNA (#2, 3,
4, 6 and 7) were all unmethylated in the three DMRs,
as were the two control samples (#1C and 5C). We also
observed a similar pattern from the group of 1-month-old
F1 mice (data not shown). However, a subset of the
6-month-old F1 mice (3 out of 10 F1) showed targetspeciﬁc changes in the methylation levels of the
YY1-associated DMRs (#9, 10 and 13; Figure 2B).
Although the littermate controls still showed typical
unmethylated DNA patterns on Peg3, Nespas and Xist
(#8C, 11, 12 and 13C), these F1 mice showed hypermethylation on these DMRs: #9 for Peg3, #10 and 13 for Xist
and #9 and 10 for Nespas. We also tested other DMRs,
including Tsix and H19, but the methylation levels on
these DMRs were not aﬀected in these F1 mice, indicating
a target-speciﬁc outcome. This hypermethylation was initially noticed due to the sudden sterility observed from one
of the ﬁve F1 male mice (#9) that had been used for our
breeding experiments (Figure 5). Since this change was
mainly observed in older mice, this outcome may not be

Nucleic Acids Research, 2009, Vol. 37, No. 17 5659

solely caused by YY1 KD during spermatogenesis.
In sum, the above experiments suggest that reduced
levels of YY1 protein during spermatogenesis may not
have any major impact on the DNA methylation levels
of the DMRs.
YY1 KD during oogenesis
To study YY1 KD during oogenesis, we prepared
50 female F1 mice (pSico-YY1, Zp3-Cre) along with 50
littermate controls (+, Zp3-Cre). We performed three different rounds of egg isolation with these 8-week-old F1
mice. In each round, 10 F1 and 10-littermate control mice
were superovulated and sacriﬁced. The remaining 20 F1
and 20 littermates were used for other breeding experiments. Each set of the 10 female mice yielded 400
mature oocytes. We did not ﬁnd any gross diﬀerence
between the F1 mice with YY1 KD and the littermate
control set in terms of morphology of mature eggs,
although the number of the isolated egg was slightly smaller in the mice with YY1 KD (Figure 3C). This suggests
that our YY1 KD scheme probably did not cause any
hindrance to the oogenesis process itself.
Due to the limited amount of egg DNA, we targeted
only ﬁve DMRs for this analysis, including H19, Nespas,
Xist, Tsix and Peg3. We successfully ampliﬁed most of
these DMRs except for Tsix. The DNA ampliﬁed from
the eggs was subsequently used to analyze the DNA
methylation levels of the DMRs (Figure 3). According
to the results from COBRA and individual sequencing,
YY1 KD during oogenesis did aﬀect the DNA methylation levels of the two YY1-associated DMRs, Peg3-DMR

and Xist-DMR. As expected, the control set showed
complete DNA methylation on these two DMRs.
However, the YY1 KD set displayed almost no methylation (100–0%) on the Peg3-DMR and much lower levels
(85–46%) of DNA methylation on the Xist-DMR. In contrast, the DNA methylation levels on the DMRs of Nespas
and H19 were similar between the YY1 KD and control
sets. These results conﬁrmed that reducing YY1 levels
during oogenesis has target-speciﬁc eﬀects on the methylation levels of the DMRs of Peg3 and Xist. This further
suggests that the proper level of YY1 protein is likely
required for de novo DNA methylation of these two
DMRs during oogenesis.
YY1 KD during the preimplantation stage
Since YY1 KD during oogenesis had a major impact on
the DNA methylation levels of the DMRs of Peg3 and
Xist, we further followed up the progression of these
changes by allowing eggs with YY1 KD to fertilize and
develop. Female F1 mice (pSico-YY1, Zp3-Cre) were
time-mated with male littermates, and used for harvesting
blastocyst-stage embryos. DNA was individually puriﬁed
from each blastocyst for genotyping. PCR-based genotyping determined the sex and presence of the pSico-YY1
allele in each blastocyst. This allowed us to group all
the retrieved blastocysts from each litter of 7–25 embryos
into four diﬀerent categories: male or female, with or without the pSico-YY1 allele. The DNA from each category of
blastocysts was combined together as a group, and used
for DNA methylation analyses as shown in Figure 4.
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Figure 3. YY1 KD eﬀects during oogenesis. About 400 eggs at MII phase were isolated from each of the following two types of female mice: the
KD mice (pScio-YY1, Zp3-Cre) and the control (Con) littermates (+, Zp3-Cre). Genomic DNA from these two types of mice was ﬁrst treated by
bisulﬁte conversion, followed by restriction enzyme digestion (A) and sequencing (B). The PCR product from the H19-ICR was digested by ClaI,
while the remaining products from the DMRs of Nespas, Peg3 and Xist were digested by TaqI. The results derived from sequencing of individual
PCR products were summarized in the following manner. Each circle represents one CpG site: closed and open ones indicate methylated and
unmethylated states, respectively, of the analyzed CpG sites. Each row represents one clone derived from the original PCR product. The methylation
levels (%) of each DMR were calculated through dividing the number of methylated CpGs by the total number of surveyed CpG sites.
We monitored and compared the purity, number and morphology of the isolated egg samples, and a representative image of the isolated egg is
also shown (C).
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Figure 5. Developmental potential of the gametes with YY1 KD. The germ cells with YY1 KD were also tested through breeding the male F1 mice
(pScio-YY1, Pro-Cre) (A) and the female F1 mice (pSico-YY1, Zp3-Cre) (B) with their littermates. These two breeding experiments were summarized
as shown on the left. The two graphs on the right represent the birth weight proﬁles derived from the 1-day-old neonates of these two breeding
experiments. The neonates were analyzed in terms of their birth weights. Each mouse was ﬁrst categorized according to its genotype [carrier (red)
versus noncarrier (blue)]. The relative weight percentile for each mouse was calculated through dividing its weight by the averaged value for its litter.
This relative weight value was used to further classify each mouse into diﬀerent categories ranging from 65% to 125% as shown on the x-axis.
The total number of mice in each weight category is plotted as a value on the y-axis.
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Figure 4. YY1 KD eﬀects during early embryogenesis. Blastocysts were isolated through crossing the female F1 mice (pSico-YY1, Zp3-Cre) with
littermate breeders. The isolated blastocysts were categorized based on their genotypes and genders. The DNA from each category of blastocysts was
ﬁrst treated with the bisulﬁte conversion, followed by the restriction digestion-based COBRA (A) and sequencing (B). The digested PCR products for
H19, Nespas and Peg3 are derived from male blastocysts, while Xist is shown in four categories due to the fact that X chromosome number varies
depending on gender. The PCR products were digested by the following restriction enzymes: H19 was digested by ClaI, while Nespas, Peg3 and Xist
were digested by TaqI. The sequencing results for Xist are from female blastocysts (Con and KD).
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Developmental potential of the germ cells with YY1 KD
The developmental potential of the germ cells with the
reduced levels of YY1 was also tested through individually
breeding each of the two following types of F1 mice: male
F1 (pSico-YY1, Pro-Cre) and female F1 (pSico-YY1,
Zp3-Cre) (Figure 5). First, we crossed the ﬁve F1 male
mice (pSico-YY1, Pro-Cre) with their littermates, yielding
over 20 litters. Out of these 20 litters, 11 were analyzed in
terms of their genotypes, sexes and birth weights
(Figure 5A). We also performed another parallel breeding
experiment with control mice lacking the pSico-YY1 allele
(+, Pro-Cre). The overall litter sizes were similar between
the test breeding (85/11) and the control breeding (80/11),
indicating no lethality during the gestation period.
Moreover, the ratio between the carriers and noncarriers
of the pSico-YY1 allele (50 : 35) was slightly higher than
the predicted ratio (1 : 1) based on Mendelian inheritance.
Although the carriers somewhat outnumbered the noncarriers, these results appear to be in a good agreement with

the previous results revealing no major impact due to
the YY1 KD during spermatogenesis (Figure 2). We
also measured the body weight of each neonate as an indicator of its health status. Each weight value was divided
by the average weight of its litter to yield a percentile score
(%). The subsequent birth weight proﬁles were compared between carrier and noncarrier groups within
the test breeding set. This comparison revealed that
carriers were slightly healthier (or heavier) than the
noncarriers. This is also consistent with the fact that the
carriers outnumbered the noncarriers (50 : 35). This
suggests that YY1 KD during spermatogenesis might
have been somehow beneﬁcial to embryo development,
although this unexpected conclusion warrants further
investigation.
In contrast, the results from the breeding of the ﬁve
female F1 mice (pSico-YY1, Zp3-Cre) with their littermates yielded a very diﬀerent outcome. The litter size
from the test breeding experiment, in which YY1 was
knock-downed, was much smaller than that of the control
breeding (88 : 132). Furthermore, the number of the carriers was much smaller than that of the noncarriers
(16 : 72) within the test breeding set. This indicated a
high incidence of lethality, about 80%, during the gestation period. This also agrees with the previous result that
YY1 KD during oogenesis had a major impact on the
methylation levels of Peg3 and Xist (Figure 3). There
was no obvious diﬀerence in terms of gender ratios in
both sets: the carrier set (female : male = 8 : 8) and the
noncarrier set (female : male = 37 : 35). In addition, the
weight proﬁle from this breeding set did not reveal any
gender-speciﬁc eﬀect within both the carrier and noncarrier sets, which could occur by the disruption of X chromosomal inactivation (Figure 5B). This is diﬀerent from
the result of a previous conditional YY1 KD using the
EIIa-Cre allele, which is designed to express the
YY1-shRNA during blastocyst stage (25). In that experiment, YY1 KD eﬀects were more pronounced in female
mice with much lighter body weight. This might simply
reﬂect the fact that the YY1 KD eﬀect during oogenesis by
the Zp3-Cre did not last long enough to be manifested in
the surviving pups. In contrast, the YY1 KD eﬀect by
EIIa-Cre targeting the blastocyst stage may have been
shown in the surviving pups more readily than that by
the Zp3-Cre. Overall, the results from the breeding experiments conﬁrmed that proper levels of YY1 protein during
oogenesis are crucial for the survival of embryos during
the later gestation period.

DISCUSSION
The current study performed a series of conditional YY1
KD experiments to characterize the roles of YY1 during
gametogenesis. According to the results, reduced YY1
levels during oogenesis had a major impact on the establishment of proper DNA methylation on the DMRs of
Peg3 and Xist. However, a similar KD during spermatogenesis had no eﬀect on the methylation levels of
the YY1-associated DMRs. This suggests that YY1
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According to the results from the COBRA analyses,
about half of DNA in the H19-DMR was methylated
and this pattern was observed among all of the diﬀerent
categories of blastocysts. This conﬁrmed that the continued YY1 KD from oogenesis to the blastocyst stage
did not have any major eﬀect on the methylation levels
of the H19-DMR. A similar conclusion has also been
drawn from the analyses on the Nespas-DMR although
the YY1 KD set showed slightly more methylation levels
than the control (Con) set. In contrast, the DMRs of Xist
and Peg3 displayed complete loss of DNA methylation
on both the YY1 KD and control sets. A similar outcome
was observed in both genders. Complete loss of DNA
methylation on the Peg3-DMR was predicted since the
majority of eggs had already lost their DNA methylation
during oogenesis (Figure 3). It is important to note that
the actual eﬀects of our conditional KD scheme are likely
manifested in a manner similar to those of maternal-eﬀect
mutations (32). All the eggs should have similar YY1 KD
eﬀects, regardless of whether they are carriers or noncarriers of the pSico-YY1 allele. Indeed, this was well
reﬂected in the results—complete loss of DNA methylation even in the control set. To further conﬁrm this possibility, we derived another set of blastocyst-stage embryos
from an independent mating between 10 F1 females
(+, Zp3-Cre) and male littermates. As shown in
Figure 4A (marked as WT), the Peg3-DMR displayed
half-methylation pattern similar to those of the two
other DMRs, H19 and Nespas. In the case of XistDMR, however, the WT sample also showed complete
loss in DNA methylation as seen in both the YY1 KD
and control sets. This suggests that the observed complete
loss of DNA methylation on the Xist-DMR is likely a
normal pattern in blastocyst-stage embryos, but not an
outcome of YY1 KD. Therefore, the analysis on the
Xist-DMR was inconclusive. Overall, the above experiments conﬁrmed that continuing YY1 KD from oogenesis
to the blastocyst stage had a consistent outcome on DNA
methylation as seen from the YY1 KD during oogenesis:
complete loss for the Peg3-DMR.
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Second, the YY1 binding sites within these DMRs are
all oriented in a same direction. This unusual unidirectionality of the YY1 binding sites might be an indication
for some unknown chromatin structures around these
DMRs. This could be also a signal for de novo
DNA methylation. According to recent ﬁndings, the
spacing between individual CTCF sites within the
H19-ICR/DMR appears to be a critical factor for maintaining the DNA methylation of this DMR (36). This
suggests that some unknown features associated with
the CTCF binding sites, such as chromatin structure,
are also important for the DNA methylation of this
DMR. In a similar line, it is important to note that the
CTCF binding sites found in the H19-DMR also share
similar unique features with the YY1 binding sites of
Peg3 and Xist: multiple binding sites with high aﬃnity
and unidirectionality (37). These shared unusual features
further support the possibility of some unique chromatin
structures around the DMRs. Therefore, it will be very
interesting to test in the near future if these features are
indeed responsible for targeting de novo methylation to
the DMRs during gametogenesis.
In contrast, a similar YY1 KD during spermatogenesis
did not cause any major impact on the DNA methylation
levels of the tested DMRs (Figure 2). This may reﬂect the
following possibilities. First, YY1 may not be involved
in establishing the DNA methylation of these DMRs
during spermatogenesis. It is important to note that the
majority of YY1-associated DMRs are not usually methylated during spermatogenesis. In this regard, the DMRs
of Xist, Nespas and Peg3 are not diﬀerent from the CpGrich promoter regions of all the other nonimprinted
genes in terms of their DNA methylation status during
spermatogenesis—no methylation. This implies that
YY1-associated DMRs could be subject to the normal
epigenetic modiﬁcations of other nonimprinted genes
without the involvement of YY1. Second, YY1 may be
required only for maintaining the unmethylated status of
these DMRs during spermatogenesis. This has been somewhat corroborated by the observation that the
YY1-associated DMRs were hypermethylated in the
older mice set of the Pro-Cre breeding experiment
(Figure 2). About 30% of the 6-month-old mice with the
YY1 KD showed a target-speciﬁc hypermethylation in
Xist, Nespas and Peg3. Since this eﬀect was observed
only in aged mice, this may not be a genuine outcome
that had been solely caused by the YY1 KD. However,
this is also a possible scenario given the fact that a similar
eﬀect was also observed in the CTCF case, where the
reduced levels of CTCF resulted in hypermethylation in
the unmethylated allele of H19 during early embryogenesis (22,23). Moreover, we believe that the detection of this
hypermethylation only in the aged mice may be related to
the timing of YY1 KD by the Pro-Cre allele. The Pro-Cre
allele is manly designed to express the YY1-shRNA at the
later stage of spermatogenesis. Thus, it is reasonable to
think that the sperm from the aged mice may have experienced the YY1 KD more likely than the sperm from the
younger male mice. In this regard, it will be interesting to
test a similar YY1 KD using diﬀerent Cre alleles, such
as tissue-nonspeciﬁc alkaline phosphatase (TNAP)-Cre,
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likely plays a role in the de novo DNA methylation of
these two DMRs during oogenesis.
So far, two transcription factors, CTCF and YY1, are
known to bind to the DMRs of imprinted domains.
According to the results from H19-ICR/DMR, CTCF is
not required for establishing the paternal-speciﬁc DNA
methylation, but acts as a protector against DNA methylation on the maternal allele during early embryogenesis
(22,23). In contrast, the results from the current study
demonstrated that YY1 is likely required for establishing
the maternal-speciﬁc DNA methylation on Peg3 and Xist
during oogenesis (Figure 3). These results are also consistent with the results from the previous studies using
in vitro and in vivo systems. In vitro YY1 KD using
Neuro2A cell lines resulted in hypomethylation of some
of the YY1-associated DMRs, such as Peg3 and Xist (24).
In vivo YY1 KD using similar transgenic mouse lines
resulted in both hyper and hypomethylation on Xist,
Nespas and Peg3 (25). The observed hypermethylation
on Peg3 and Xist from the previous study, however,
might be an unrelated side eﬀect of YY1 KD experiments
since this was observed only at that time. On the other
hand, we have consistently observed hypomethylation on
Peg3 and Xist throughout this series of YY1 KD experiments. This suggests that the hypomethylation on Peg3
and Xist is most likely a genuine outcome of the reduced
levels of YY1. If that is the case, the result presented in
this study further suggests a previously unrecognized role
for YY1, targeting de novo DNA methylation to the
DMRs of Peg3 and Xist. YY1 has never been described
before as a targeting protein for de novo DNA methylation, but this is a likely scenario given the large number of
YY1-interacting partners, especially histone-modifying
enzymes such as PRMT1 and SFMBT2 (33,34). It is
plausible to think that some of these histone-modifying
partners pre-mark the DMRs of Xist and Peg3 for
DNA methylation during oogenesis. Therefore, it will be
very interesting to test this predicted role of YY1 in the
near future.
The current study suggests the intriguing possibility
that YY1 may target de novo DNA methylation to the
DMRs of Peg3 and Xist during oogenesis. However,
YY1 binding sites are not limited to these DMRs:
these sites are found in the promoters of numerous
genes, and also in many repetitive regions of the vertebrate genomes. Then, what are the unique features associated with Peg3 and Xist that might signal for de novo
methylation during oogenesis? We believe that this
speciﬁcity might originate from the unusual features
associated with the YY1 binding sites of these two
DMRs. First, these DMRs have clusters of multiple
YY1 binding sites, on average seven sites for the XistDMR (500 bp in length) and 12 sites for the Peg3-DMR
(2 kb in length) (13,35). Besides, these YY1 binding sites
appear to be the strongest binding sites for the YY1
protein (35). The local concentration of the YY1 protein
around these DMRs might be much higher than the rest
of the genome due to the high densities of multiple YY1
binding sites giving the strongest binding aﬃnity. These
unusually high levels of YY1 protein might be a targeting signal for de novo methylation to these DMRs.
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which targets much earlier stages of gametogenesis (38). In
sum, the YY1 KD during spermatogenesis appears to
have no major eﬀect so far, but we may need to perform
more experiments to further conﬁrm this conclusion.
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